Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $6.9700 (-1.41%) ($6.9100 - $6.9700) on Sat. Aug. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.21% (three month average) | RSI | 47 | Latest Price | $6.9700(-1.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2% a day on average for past five trading days. | Weekly Trend | BCRX declines -4.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting BCRX price | BCRX will decline at least -1.605% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.605% (StdDev 3.21%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.2(-117.22%) | Resistance Level | $7.27 | 5 Day Moving Average | $6.94(0.43%) | 10 Day Moving Average | $7.08(-1.55%) | 20 Day Moving Average | $7.27(-4.13%) | To recent high | -21.3% | To recent low | 4% | Market Cap | $N/A | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |